Effects of point application and ear point pressing therapy plus nasal spray on inflammatory cells and immune function in patients with allergic rhinitis

To observe the effects of point application, ear point pressing therapy, plus mometasone furoate nasal spray on inflammatory cells and immune function in patients with allergic rhinitis (AR).

Fifty AR patients who received point application, ear point pressing therapy, and mometasone furoate nasal spray for treatment were recruited as an observation group. Simultaneously, another 50 AR patients who only used the same nasal spray were enrolled as a control group. The clinical efficacy was compared between the two groups, and the inflammatory cell count and immune function changes were observed after treatment.

The observation group had a higher total effective rate than the control group (P<0.05). After treatment, significant decreases were noticed in the total nasal symptom score, eosinophils count in nasal secretions, and serum immunoglobulin E (IgE) level in both groups (P<0.05), and the observation group was significantly lower than the control group (P<0.05).

Combining point application, ear point pressing therapy, and mometasone furoate nasal spray can produce satisfactory treatment results for AR. This method is safe and can reduce inflammatory responses and improve immune function.